February 2012

Outsourcing: Enhance, Support, Grow

January 27, 2012

You cannot do today’s job with yesterday’s methods and be in business tomorrow.” The wise words of Nelson Jackson should be the driving force behind every outsourcing partnership today. Implementing innovative strategies through outsourcing helps pharmaceutical companies meet the changing demands of the marketplace and realize their long-term goals. There might be some uncertainties around […]

Commercialization – Decisions, Decisions, Decisions

January 27, 2012

In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to make up the gaping hole left by blockbuster patent expiries. To […]

Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients

January 27, 2012

Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers are under tremendous pressure to see as many patients as possible each day, and they have very […]

The Emergence of Strategic Outsourcing in Clinical Supply Chain Management

January 27, 2012

Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a “preferred provider” model in which five to 10 providers were being used for […]

Why Outsourcing Patient Enrollment to a Specialist Makes Sense

January 27, 2012

Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the cost. Among CROs and sponsors, this expense has been […]

SHOWCASE FEATURE: Help from The Outside

January 27, 2012

Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and ­outsourcing them to third-party partners. “Successful outsourcing depends upon well-defined objectives and deliverables, a clear understanding of respective roles […]

Trends, Challenges, and Best Practices of Global Product Launches

January 27, 2012

Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is nothing really global about a global launch. Instead, it is more a region-by-region […]

C-Suite CROs

January 27, 2012

Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of $11.43 billion in 2010 and estimates that the sector will top $20.09 billion in 2017. According to a recent Frost & Sullivan report, the U.S. CRO market bucked the trend amidst […]

Transformative Leadership

January 27, 2012

Taren Grom Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company, is leading her company to achieve an audacious goal: curing cancer. We are what we repeatedly do…excellence, then, is not so much an act, but a habit.” This Aristotle quote is one of Deborah Dunsire, M.D.’s favorite expressions. As president and […]

UK Revival: Rebuilding a Life Sciences World Leader

January 27, 2012

Kim Ribbink A long history as a world leader in innovation, talented scientists from well-respected ­ universities, mature biotech clusters, and government incentives to attract innovative ­companies give the U.K. a clear edge, but this great scientific nation still has challenges with which to contend. The United Kingdom life-sciences industry is one of the world […]

What’s Ahead for Biosimilars

January 27, 2012

Denise Myshko Uncertainty lies ahead for the biosimilar market, as manufacturers await FDA guidance. Biosimilars could represent a multi-billion dollar market in the United States, although some questions remain, including the uptake by physicians and payers, pricing of biosimilars, and how the Food and Drug Administration will review such products. Alan Sheppard, global head of […]

Generics: Front and Center

January 27, 2012

The generic drug era is impacting all areas of the ­ industry as the demand for cost-effective medications increases. Denise Myshko As the demand for generics increases, originator companies are moving beyond the traditional end-of-cycle strategies and are deploying more aggressive tactics to not only protect their brands but to market their own generics. David […]

Digital Patient-Centric Communications: Listen and Learn

January 27, 2012

Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the universe has conditioned the industry to turn a deaf ear […]

Safety and Pharmacovigilance: A Moving Target

January 27, 2012

Robin Robinson The industry has always been under ­extreme scrutiny by regulators and the ­public, but the current business ­environment creates even more pressure on the pharmaceutical industry to stay compliant. Regulations and procedures are not only tightening but continually developing and changing in the United States and abroad. Keeping on top of compliance in […]

Last Word

January 27, 2012

Creating Jobs in the Industry Safi Bahcall, Ph.D., CEO, Synta Pharmaceuticals, ­discusses how the extension of the R&D tax credit for life-sciences companies can accelerate job creation. PV: What do you think employment within the ­industry will look like in 2012? Bahcall: As the U.S. economy continues to recover, albeit slowly, my hope is that […]

Talent Pool

January 27, 2012

executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Aaron BERG Essentialis Names CEO Essentialis, a pharmaceutical company focused on a novel medicine for the treatment of cardiovascular and metabolic disease, has promoted Aaron Berg to CEO, from president and chief commercial officer. Mr. Berg joined Essentialis in January 2010, bringing […]

PharmaTrax

January 27, 2012

Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Life-Sciences Companies Face Increased Complexity in Aggregate Spend Tracking and Reporting Trend: Aggregate spend mandates within the life-sciences industry are continuing to evolve in 2012 amid ongoing changes to state disclosure laws, the addition of new corporate integrity and deferred prosecution agreements, and institutional […]

Social Media

January 26, 2012

Social Media trends, regs, and apps By Robin Robinson Palio Launches Wiki for Healthcare and ­Pharmaceutical Apps Trend Watch: Use of wikis to monitor social media activity spreads to apps. Our PharmApps wiki gives users the ability to comment, write a review, rate apps, share, and upload new apps, says Mike Myers, President of Palio. […]

Tools of the Trade

January 26, 2012

New electronic and web-based applications, sites, and technologies By Carolyn Gretton New Tool from HRM Aims to Improve Medication Adherence, Patient Outcomes Trend: A growing number of healthcare providers are using intuitive technological tools to connect ­directly with patients to provide information and education for improving medication adherence. Housecalls is a technology-enabled communications platform from […]

What’s New

January 26, 2012

New healthcare-related products, services, and companies By Carolyn Gretton New Alliance Promotes Trust in Online Physician Research Trend: Market research organizations, which base many critical decisions on insights from online ­physician panels, are taking collective action to ensure the integrity of the respondents and data ­collected. The Trust Alliance is a new nonprofit organization that […]

UpFront

January 26, 2012

INDUSTRY at Large Milestones… Spectrum Celebrates 15 Years Spectrum, a health and science communications agency, is ­celebrating its 15th ­anniversary. The independent agency, which was founded by John Seng in 1996, is ­committed to achieving the goals of clients who are involved with issues, products, provider services or research in life and human health sciences. […]

Letter from the Editor

January 26, 2012

New commercial models paying dividends… Creating value — the goal for all companies — and how they achieve this goal are as different as the companies themselves. According to a recent report — Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Challenging Business Environment — from The Boston […]

FEEDBACK